Overview
- The Court granted review on Jan. 16 in Monsanto v. Durnell, a Missouri case upholding a $1.25 million verdict for a man who developed non‑Hodgkin’s lymphoma.
- The case tests whether the Federal Insecticide, Fungicide, and Rodenticide Act blocks label‑based failure‑to‑warn suits when EPA has not required a cancer warning on Roundup.
- The U.S. Solicitor General urged review supporting Bayer, citing EPA findings that glyphosate is not likely carcinogenic and repeated approval of labels without cancer warnings.
- A ruling could affect tens of thousands of claims and billions in potential liability, as Bayer has paid about $10 billion, reserved $16 billion, removed glyphosate from consumer Roundup, and kept it in agricultural products.
- Arguments are expected in the spring with a decision likely by late June or early July.